Isogenica is pleased to be attending and presenting at PEGS Europe 2019.
Our CSO Guy Hermans will be presenting about the design and validation of llamdA, Isogenica's fully synthetic camelid single domain antibody library. Here, we will disclose novel data on the design and validation of a humanized variant of the library. Examples will be provided on how this library, combined with our CIS Display enabled high throughput screening method, can generate high affinity lead panels in weeks rather than months.
Business Director of Business Development David Mead also be representing Isogenica.
Download our infographic VHH as biotherapeutics